DK1166775T3 - Målrettet liposomgenafgivelse - Google Patents
Målrettet liposomgenafgivelseInfo
- Publication number
- DK1166775T3 DK1166775T3 DK01123562.9T DK01123562T DK1166775T3 DK 1166775 T3 DK1166775 T3 DK 1166775T3 DK 01123562 T DK01123562 T DK 01123562T DK 1166775 T3 DK1166775 T3 DK 1166775T3
- Authority
- DK
- Denmark
- Prior art keywords
- gene delivery
- targeted liposome
- liposome gene
- virus
- targeted
- Prior art date
Links
- 239000002502 liposome Substances 0.000 title abstract 2
- 238000001476 gene delivery Methods 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 2
- 239000003446 ligand Substances 0.000 abstract 1
- 238000012385 systemic delivery Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6618897P | 1997-11-19 | 1997-11-19 | |
| US8317598P | 1998-04-27 | 1998-04-27 | |
| EP98958643A EP1032369B1 (en) | 1997-11-19 | 1998-11-19 | Targeted liposome gene delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1166775T3 true DK1166775T3 (da) | 2010-05-03 |
Family
ID=26746455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01123562.9T DK1166775T3 (da) | 1997-11-19 | 1998-11-19 | Målrettet liposomgenafgivelse |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP1166775B1 (da) |
| JP (2) | JP2001522871A (da) |
| CN (3) | CN1904055A (da) |
| AT (2) | ATE295722T1 (da) |
| AU (1) | AU759164C (da) |
| CA (1) | CA2308584C (da) |
| DE (2) | DE69830249T2 (da) |
| DK (1) | DK1166775T3 (da) |
| ES (1) | ES2339421T3 (da) |
| HK (1) | HK1045641B (da) |
| PT (1) | PT1166775E (da) |
| WO (1) | WO1999025320A1 (da) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7780882B2 (en) | 1999-02-22 | 2010-08-24 | Georgetown University | Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent |
| ATE511543T1 (de) | 1999-02-22 | 2011-06-15 | Univ Georgetown | Immunoliposome mit einem targeting- antikörperfragment zur systemischen genverabreichung |
| US8617514B2 (en) | 1999-02-22 | 2013-12-31 | Georgetown University | Tumor-targeted nanodelivery systems to improve early MRI detection of cancer |
| US9034329B2 (en) | 1999-02-22 | 2015-05-19 | Georgetown University | Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| US7109165B2 (en) * | 2001-05-18 | 2006-09-19 | Sirna Therapeutics, Inc. | Conjugates and compositions for cellular delivery |
| WO2004066908A2 (fr) * | 2003-01-17 | 2004-08-12 | Sanofi Pasteur | Composition comprenant lipides cationiques et un polynucleotide ou un polpeptide et methode pour leur delivrance ciblee |
| US20040241088A1 (en) * | 2003-01-28 | 2004-12-02 | Georgetown University | Method for evaluating the efficacy of certain cancer treatments |
| CN1327899C (zh) * | 2003-05-10 | 2007-07-25 | 彭朝晖 | 腺病毒载体与p53基因的基因重组体的应用 |
| PT1633327E (pt) * | 2003-06-04 | 2010-11-08 | Univ Georgetown | Método para melhoramento da estabilidade e duração de armazenamento de complexos lipossomais |
| US8627821B2 (en) | 2005-01-10 | 2014-01-14 | Pulmatrix, Inc. | Method and device for decreasing contamination |
| WO2007061141A1 (ja) * | 2005-11-24 | 2007-05-31 | Genomidea, Inc. | 改変パラミクソウイルスおよびその作製方法 |
| MX2008014362A (es) | 2006-05-15 | 2008-11-27 | Univ Georgetown | Preparacion de inmunoliposomas dirigidos a anticuerpos o a fragmentos de anticuerpos para la administracion sistemica de agentes terapeuticos o de diagnostico y usos de los mismos. |
| CN102133404B (zh) * | 2011-03-23 | 2013-01-16 | 成都诺恩生物科技有限公司 | 一种肿瘤靶向治疗药物载体、其制备方法及其应用 |
| US20130177629A1 (en) | 2011-12-22 | 2013-07-11 | Nuvo Research Gmbh | Liposomal compositions |
| US20140120157A1 (en) | 2012-09-19 | 2014-05-01 | Georgetown University | Targeted liposomes |
| SG2013014170A (en) | 2012-09-19 | 2014-04-28 | Univ Georgetown | Targeted liposomes |
| WO2014159917A2 (en) | 2013-03-14 | 2014-10-02 | Georgetown University | Treatment for exposure to nerve agent |
| CA3001054C (en) | 2015-10-08 | 2021-12-14 | University Of Utah Research Foundation | Elephant p53 proteins and nuleic acids encoding the same for preventing or treating cancer |
| EP3538546B1 (en) | 2016-11-14 | 2025-01-08 | Novartis AG | Compositions, methods, and therapeutic uses related to fusogenic protein minion |
| US12274784B2 (en) | 2018-10-12 | 2025-04-15 | Synergene Therapeutics, Inc. | Methods for reducing side effects of immunotherapy |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5635380A (en) * | 1994-01-18 | 1997-06-03 | Vanderbilt University | Enhancement of nucleic acid transfer by coupling virus to nucleic acid via lipids |
| US5928944A (en) * | 1994-02-04 | 1999-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Method of adenoviral-medicated cell transfection |
| HUT77263A (hu) * | 1994-09-13 | 1998-03-02 | Theratech Inc. | Kémiai anyagok bejuttatása egy specifikus sejttípus sejtjeinek belsejébe |
| US20020051767A1 (en) * | 1995-09-13 | 2002-05-02 | Yawen L. Chiang | Cancer treatment |
| JPH09110722A (ja) * | 1995-10-20 | 1997-04-28 | Toray Ind Inc | 抗腫瘍活性物質の腫瘍細胞内導入用イムノリポソーム及びその調製法 |
| EP0904100B1 (en) * | 1996-02-09 | 2006-07-26 | Pi-Wan Cheng | Cationic lipid and receptor ligand-facilitated delivery of biologically active molecules |
| JP3956402B2 (ja) * | 1996-03-04 | 2007-08-08 | 日本油脂株式会社 | アンホテリシンb運搬体 |
-
1998
- 1998-11-19 AU AU14642/99A patent/AU759164C/en not_active Ceased
- 1998-11-19 CN CNA2006101003252A patent/CN1904055A/zh active Pending
- 1998-11-19 ES ES01123562T patent/ES2339421T3/es not_active Expired - Lifetime
- 1998-11-19 CN CN2004100824737A patent/CN1616665B/zh not_active Expired - Fee Related
- 1998-11-19 JP JP2000520754A patent/JP2001522871A/ja active Pending
- 1998-11-19 CN CNB988131773A patent/CN1191094C/zh not_active Expired - Fee Related
- 1998-11-19 EP EP01123562A patent/EP1166775B1/en not_active Expired - Lifetime
- 1998-11-19 AT AT98958643T patent/ATE295722T1/de not_active IP Right Cessation
- 1998-11-19 CA CA2308584A patent/CA2308584C/en not_active Expired - Fee Related
- 1998-11-19 DK DK01123562.9T patent/DK1166775T3/da active
- 1998-11-19 PT PT01123562T patent/PT1166775E/pt unknown
- 1998-11-19 DE DE69830249T patent/DE69830249T2/de not_active Expired - Lifetime
- 1998-11-19 AT AT01123562T patent/ATE459340T1/de not_active IP Right Cessation
- 1998-11-19 WO PCT/US1998/024657 patent/WO1999025320A1/en not_active Ceased
- 1998-11-19 DE DE69841536T patent/DE69841536D1/de not_active Expired - Lifetime
- 1998-11-19 EP EP98958643A patent/EP1032369B1/en not_active Expired - Lifetime
-
2002
- 2002-07-02 HK HK02104922.3A patent/HK1045641B/en not_active IP Right Cessation
-
2010
- 2010-08-19 JP JP2010184261A patent/JP2010263920A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1616665A (zh) | 2005-05-18 |
| EP1032369B1 (en) | 2005-05-18 |
| CA2308584A1 (en) | 1999-05-27 |
| DE69841536D1 (de) | 2010-04-15 |
| JP2001522871A (ja) | 2001-11-20 |
| HK1045641A1 (en) | 2002-12-06 |
| DE69830249D1 (de) | 2005-06-23 |
| DE69830249T2 (de) | 2006-05-04 |
| PT1166775E (pt) | 2010-04-16 |
| HK1035490A1 (en) | 2001-11-30 |
| CN1191094C (zh) | 2005-03-02 |
| CN1286630A (zh) | 2001-03-07 |
| ATE459340T1 (de) | 2010-03-15 |
| AU1464299A (en) | 1999-06-07 |
| AU759164B2 (en) | 2003-04-10 |
| CN1616665B (zh) | 2010-10-06 |
| CA2308584C (en) | 2011-07-19 |
| WO1999025320A1 (en) | 1999-05-27 |
| JP2010263920A (ja) | 2010-11-25 |
| ES2339421T3 (es) | 2010-05-20 |
| HK1078608A1 (en) | 2006-03-17 |
| EP1166775A3 (en) | 2003-06-25 |
| ATE295722T1 (de) | 2005-06-15 |
| AU759164C (en) | 2007-03-29 |
| CN1904055A (zh) | 2007-01-31 |
| HK1045641B (en) | 2010-10-29 |
| EP1032369A1 (en) | 2000-09-06 |
| EP1166775B1 (en) | 2010-03-03 |
| EP1166775A2 (en) | 2002-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1166775T3 (da) | Målrettet liposomgenafgivelse | |
| ATE273320T1 (de) | Fusogene liposomen | |
| BR9801027B1 (pt) | sistema de distribuiÇço de medicamentos. | |
| NO994837L (no) | Intravesikal medikamentavleveringssystem | |
| IS1950B (is) | Arýlsúlfonýlamínó hýdroxamsýruafleiður, notkun þeirra, ásamt lyfjablöndum | |
| IS5130A (is) | Arýlsúlfonýlamínó hýdroxamsýruafleiður, notkun þeirra, ásamt lyfjablöndum | |
| DE69637147D1 (de) | Transportproteine und deren verwendungen | |
| TR199901949T2 (xx) | Lemfositik t�m�rler i�in �areler. | |
| ID29405A (id) | Protein antigen tumor sart-3 yang baru dan peptida-peptida antigen tumornya | |
| EP0666313A3 (en) | Telomerase as a target in cancer gene therapy. | |
| AU6987696A (en) | The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells | |
| DE59811071D1 (de) | Präparation umfassend Thiolgruppen-haltige Proteine | |
| DE3673436D1 (de) | Gene fuer biologisch aktive proteine. | |
| FI971377L (fi) | Adenovirusperäisiä virusvektoreita, joissa on kaksi terapeuttista geeniä: itsemurha- ja immuunistimuloiva geeni | |
| DK1140994T3 (da) | Ydre overflade-proteiner, gener herfor samt anvendelse deraf | |
| IT1316400B1 (it) | Complesso integrale giogo di supporto e imbracatore. | |
| EP1124840A4 (en) | GENES AND PROTEINS SPECIFIC TO OVARIES | |
| WO2001009173A3 (fr) | Utilisation des acides quinique, shikimique et de leurs derives pour la preparation de ligands du recepteur du mannose | |
| RU97115918A (ru) | Средство, модифицирующее пролиферацию, функциональную активность и гибель нормальных и опухолевых клеток | |
| EP1041146A4 (en) | TUMOR ANTIGEN PROTEIN, ITS GENE AND ITS USE | |
| NO20020604D0 (no) | Fremgangsmåte for avlevering av terapeutiske midler ved bruk av en dekstrinlösning | |
| ATE222263T1 (de) | Prostata-spezifische antigen inhibitore | |
| 杨阳 | A Life Cant't Be Killed So Simply—Continuation of The Kitten from Chapter I of Black Boy | |
| ATE55618T1 (de) | Gene fuer biologisch aktive proteine. | |
| AU1687201A (en) | A recombinant virus killing specifically eb-related tumor, the method for constructing and propagating it and the use thereof |